Finding ways to detect your risk for cancer, infections and other diseases before you experience any symptoms is the goal of the Early Detection Research Program at the HonorHealth Research Institute.
The program offers a personalized approach to cancer risk assessment through testing and consultations that may include:
- Family history assessment and medical exam.
- Genetic counseling and testing.
- Blood testing.
- Nutrition consultation.
- Risk-reducing surgery (if applicable).
The program is initially focused on pancreatic cancer risk assessments, with plans to expand offerings to breast, ovarian and other diseases.
Pancreatic Cancer Risk Assessment Study
The institute's Early Detection Research Program is leading risk-prediction clinical research for pancreatic cancer that will:
- Evaluate risk criteria for pancreatic cancer.
- Establish a database to delineate patterns of characteristics specific to pancreatic cancer.
- In the future, use biomarkers to aid in the early detection of pancreatic cancer.
The study will closely monitor participants for many years. You may be eligible based on nationally established risk-assessment criteria including:
- Your family history.
- A higher-than-average risk of developing pancreatic cancer.
- Identification of hereditary mutations that indicate an increased risk of developing pancreatic cancer. or
- A diagnosis of intraductal papillary mucinous neoplasm, a type of tumor that grows within the pancreatic ducts.
If you're eligible for the pancreatic cancer study, you may undergo:
- A thorough history and physical exam.
- Genetic testing for hereditary mutations.
- Routine blood tests along with a test for a specific tumor marker.
- Magnetic resonance cholangiopancreatography, or MRCP, a procedure that visualizes bile and pancreatic ducts.
- A gastroenterology consult.
- Endoscopic ultrasound.